Linked Data API

Show Search Form

Search Results

1689223
registered interest false more like this
date less than 2024-02-16more like thismore than 2024-02-16
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Liver Diseases more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how many and what proportion of hospital admissions were due to liver disease in 2022-23. more like this
tabling member constituency Bath more like this
tabling member printed
Wera Hobhouse remove filter
uin 14150 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-02-21more like thismore than 2024-02-21
answer text <p>The Office for Health Improvement and Disparities publishes liver disease profiles. These provide data on the number and rate of hospital admissions for liver disease in England and local areas. The profiles currently include hospital admissions data up to the financial year ending 31 March 2022.</p><p>In the financial year ending 2022, there were 82,290 hospital admissions in England due to liver disease. The profiles do not include the proportion of all hospital admissions that are due to liver disease. Data on hospital admissions is updated regularly in the profiles, and data for the financial year ending 2023 will be published this summer.</p> more like this
answering member constituency Pendle more like this
answering member printed Andrew Stephenson more like this
question first answered
less than 2024-02-21T16:14:41.073Zmore like thismore than 2024-02-21T16:14:41.073Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
4602
label Biography information for Wera Hobhouse more like this
1666221
registered interest false more like this
date less than 2023-10-19more like thismore than 2023-10-19
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Fractures: Health Services more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, whether he plans to provide additional funding to extend the provision of fracture liaison services to all NHS trusts. more like this
tabling member constituency Bath more like this
tabling member printed
Wera Hobhouse remove filter
uin 203557 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-10-24more like thismore than 2023-10-24
answer text <p>On 24 January 2023, we announced our plan to publish the Major Conditions Strategy. The Strategy will focus on six major groups of conditions, including musculoskeletal (MSK) disorders such as osteoporosis.</p><p>We have now published our initial report ‘Major Conditions Strategy: Case for change and our strategic framework’. It sets out what we have learned so far, and shares what we plan to focus on next to develop the final strategy.</p><p>For MSK conditions, it sets out that we will look to aim to improve services where medical treatment is necessary. Together with NHS England, we will explore supporting the further provision of fracture liaison services. This could include identifying people at risk of further osteoporotic fragility fracture and implementing strategies to reduce the risk of future fracture, including falls, and mortality.</p> more like this
answering member constituency Colchester more like this
answering member printed Will Quince more like this
question first answered
less than 2023-10-24T15:23:40.683Zmore like thismore than 2023-10-24T15:23:40.683Z
answering member
4423
label Biography information for Will Quince more like this
tabling member
4602
label Biography information for Wera Hobhouse more like this
1663486
registered interest false more like this
date less than 2023-10-13more like thismore than 2023-10-13
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Haemochromatosis more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of the scope of draft NICE guidelines on haemochromatosis with regards to (a) known forms of haemochromatosis and (b) pathogenic variants attributable to other genetic mutations associated with iron overload. more like this
tabling member constituency Bath more like this
tabling member printed
Wera Hobhouse remove filter
uin 201340 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-10-18more like thismore than 2023-10-18
answer text <p>The Department has made no such assessment. The National Institute for Health and Care Excellence (NICE) reviewed its guidelines portfolio in May 2023 to identify topics that it thinks will add the most value to the health and care system, considering key factors such as clinical benefit, cost effectiveness, the potential to increase productivity and support workforce issues and the potential to address health inequalities. As a result, NICE identified several topics, including the guidance on haemochromatosis, where work will stop for the time being to allow focus on key priorities. NICE consulted on the scope for the guideline on haemochromatosis in January 2023 but has not published the final scope.</p><p>These topics will be reconsidered by NICE’s new Prioritisation Board that is being established by its Chief Medical Officer, and as work to establish the prioritisation board progresses, more information on timescales will become available. NICE will make further information available on its website once topics have been reprioritised.</p>
answering member constituency Colchester more like this
answering member printed Will Quince more like this
grouped question UIN 201341 more like this
question first answered
less than 2023-10-18T15:43:47.73Zmore like thismore than 2023-10-18T15:43:47.73Z
answering member
4423
label Biography information for Will Quince more like this
tabling member
4602
label Biography information for Wera Hobhouse more like this
1663487
registered interest false more like this
date less than 2023-10-13more like thismore than 2023-10-13
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Haemochromatosis more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what information his Department holds on the reasons for which the drafting process for NICE guidelines on haemochromatosis was paused in April 2023. more like this
tabling member constituency Bath more like this
tabling member printed
Wera Hobhouse remove filter
uin 201341 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-10-18more like thismore than 2023-10-18
answer text <p>The Department has made no such assessment. The National Institute for Health and Care Excellence (NICE) reviewed its guidelines portfolio in May 2023 to identify topics that it thinks will add the most value to the health and care system, considering key factors such as clinical benefit, cost effectiveness, the potential to increase productivity and support workforce issues and the potential to address health inequalities. As a result, NICE identified several topics, including the guidance on haemochromatosis, where work will stop for the time being to allow focus on key priorities. NICE consulted on the scope for the guideline on haemochromatosis in January 2023 but has not published the final scope.</p><p>These topics will be reconsidered by NICE’s new Prioritisation Board that is being established by its Chief Medical Officer, and as work to establish the prioritisation board progresses, more information on timescales will become available. NICE will make further information available on its website once topics have been reprioritised.</p>
answering member constituency Colchester more like this
answering member printed Will Quince more like this
grouped question UIN 201340 more like this
question first answered
less than 2023-10-18T15:43:47.76Zmore like thismore than 2023-10-18T15:43:47.76Z
answering member
4423
label Biography information for Will Quince more like this
tabling member
4602
label Biography information for Wera Hobhouse more like this